More than 150 years of Rentschler

Entrepreneurial courage gives wings to innovation, regions, people, and entire generations: In 1872, strategically located on the Swabian Railway, the “7-Swabians Pharmacy” was established in Laupheim. This is our foundation from which we produce biopharmaceuticals for serious or rare diseases as a leading global contract development and manufacturing organization (CDMO). With subsidiaries in Milford (Boston, MA, USA) and Stevenage (UK), we have considerably expanded our presence and expertise, including in the field of cell and gene therapy.

Milestones

Rentschler Biopharma History 1872

1872

Our roots go back to the G. Müller Pharmacy in Laupheim

1927 Rentschler Biopharma Melabon

1927

Foundation as a pharmaceutical manufacturer

Rentschler Biopharma History 1974

1974

Installation of the biotechnology divison

Rentschler Biopharma History 1979

1979

Start working with recombinant cell lines

Rentschler Biopharma History 1979 1983  Fiblaferon

1983

World's first market approval for a natural Interferon-ß (Fiblaferon)

Rentschler Biopharma History 1989

1989

Approval of a recombinant Interferon-y (Polyferon) and a topical Interferon-ß-gel

Rentschler Biopharma History 1997

1997

Entering the business of a contract development and manufacturing of biopharmaceuticals

Rentschler Biopharma History 2006

2006

Foundation of Rentschler Biopharma Inc.

Rentschler Biopharma History 2008

2008

Extension of manufacturing facilities (1 x 3,000 L stainless steel, 2 x 1,000 L single-use bioreactors)

Rentschler Biopharma History 2013

2013

Implementing of own Combined Heat and Power plant

Rentschler Biopharma History 2014

2014

Launch of proprietary cell line development platform TurboCellTM

Rentschler Biopharma History 2015

2015

Manufacturing starts in the first 2,000 L single-use bioreactor

Rentschler Biopharma Aerial shot Laupheim site

2016

Expansion of manufacturing capacity

2x 3,000 L twin facility, second 2,000 L single-use bioreactor

Rentschler Biopharma History 2017 Leukocare strategic alliance

2017

Alliance between Rentschler Biopharma and Leukocare

Rentschler Biopharma will acquire a 10 % stake in Leukocare

Rentschler Biopharma History 2019 Milford Acquisition

2019

Acquisition of site in Milford, MA, USA

Rentschler Biopharma CDMO Xpert alliance Vdsc automatic vial filler

2020

Strategic collaboration with Vetter

Rentschler Biopharma History 2020 Entrance in mRna Technology

2020

Entry into mRNA Technology

Rentschler Biopharma Building in Stevenage UK

2021

New Modalities and site in Stevenage, UK

Rentschler Biopharma History 2021 New Bioreactor Installation

2021

Capacity Expansion with 2,000-liter bioreactor

Rentschler Biopharma History 2021 RBMC US Groundbreaking Milford Site

2021

Groundbreaking at new Rentschler Biopharma Manufacturing Center US, Milford, MA

Rentschler Biopharma 150 years

2022

150 years of Rentschler

Get in Touch with our Communications Team

Dr. Latika Bhonsle-Deeng
Head of Communications and Spokesperson

*Required Fields